Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT01629082

Completed

Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia

Bone Marrow Diseases | Chronic Myelomonocytic Leukemia | Neutropenia | Acute Myeloid Leukemia (AML) | Myeldysplastic Syndrome (MDS)
NCT02058901

Completed

Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors.

Solid Tumors
NCT02876354

Completed

Risk Factors for Vascular Calcifications in Hemodialysis Patients: to What Extent is Vitamin K2 Deficiency Involved?

Vascular Calcifications
NCT00531544

Completed

A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248

Metastatic Renal Cell Carcinoma
NCT00459875

Completed

Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer

Kidney Cancer
NCT00923117

Terminated

Sunitinib to Treat Recurrent Brain Cancer

Glioblastoma Multiforme | Malignant Gliomas | Anaplastic Gliomas
NCT01121562

Completed

Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors

Pancreatic Neuroendocrine Tumors
NCT00361309

Completed

SU011248 in Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma | Liver Cancer
NCT00006014

Completed

SU5416 in Treating Patients With Malignant Mesothelioma

Malignant Mesothelioma
NCT01069770

Unknown

Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC)

Clear Cell Renal Cell Carcinoma | Metastasis
NCT00411151

Completed

Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer

Gastric Adenocarcinoma | Barrett Esophagus
NCT00078000

Completed

A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.

Breast Neoplasms
NCT06662253

Not yet recruiting

Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: a Multicentre Pilot Randomized Trial (PrOVE iT)

Venous Thromboembolism (VTE) | Trauma Related Injuries
NCT04357015

Unknown

Intravenous Tranexamic Acid Versus IV Carbetocin in Abdominal Myomectomy

Myomectomy
NCT04756765

Withdrawn

Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer

Breast Cancer | Advanced Breast Cancer
NCT02499497

Completed

A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer

Prostate Cancer
NCT01205555

Terminated

Combining LHu With Ultrasound Monitoring in IUI

Infertility
NCT07075757

Not yet recruiting

In Situ Injection of Anti-angiogenics in Patients With Brain Arteriovenous Malformations Not Eligible for Exclusion Treatment (BLITZ)

Brain Arteriovenous Malformations
NCT02775773

Completed

Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH (TRANOXY2016)

Post Partum Haemorrhage
NCT01884740

Terminated

Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22

Glioblastoma Multiforme | Anaplastic Astrocytoma | Diffuse Intrinsic Pontine Glioma | Brain Stem Glioma | Pilomyxoid Astrocytoma | Glioma of Brainstem | Fibrillary Astrocytoma of Brain | Mixed Oligodendroglioma-Astrocytoma
NCT05414149

Completed

Efficacy and Safety Comparison of IVR and IVC Before Vitrectomy in Proliferative Diabetic Retinopathy

Proliferative Diabetic Retinopathy
NCT03066427

Completed

Study to Evaluate Efficacy and Safety of Sunitinib in Renal Cell Carcinoma Progressed to 1L Immunotherapy Treatment. (INMUNOSUN)

Clear Cell Renal Carcinoma
NCT04520620

Withdrawn

Concentration-effect Relationship of Enoxaparin for Thromboembolic Prevention (COV-ENOX)

Sars-CoV2
NCT03493087

Completed

Underlying Causes of Low Vitamin K Status in Hemodialysis Patients

Renal Insufficiency, Chronic
NCT03091569

Completed

Effects of Vitamin K on Redness Associated With Injection Site Reactions in Participants Treated With Plegridy (VITALITY)

Relapsing-Remitting Multiple Sclerosis
NCT02707263

Withdrawn

Effect of Intravenous Continuous Infusion Heparin on Rates of Venous Thromboembolism in High-Risk, Critically Ill Patients

Venous Thromboembolism
NCT02848768

Completed

Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma (RTKI)

Metastatic Clear Cell Renal Cell Carcinoma
NCT00864864

Completed

Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma

Glioblastoma | Brain Tumor
NCT02572336

Unknown

A Study of the Safety, Imaging and Clinical Outcomes of THR-18 in Acute Stroke Subjects Treated With tPA

Ischemic Stroke
NCT00006013

Completed

SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm
NCT00189176

Completed

Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis
NCT00003720

Completed

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Sarcoma
NCT00790595

Completed

Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical Prostatectomy

Prostate Cancer
NCT00094029

Approved for marketing

A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248

Gastrointestinal Neoplasm
NCT01469377

Completed

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Major Depressive Disorder
NCT07361159

Recruiting

Health and Wellness Coaching to Improve Thoracic Transplant Caregiver Self-Efficacy

Wellbeing
NCT07222891

Not yet recruiting

Impact of Smell Testing on Health Outcomes

Wellbeing | Olfactory Dysfunction
NCT06881303

Not yet recruiting

Impact of Prior Identification and Education of Patients Requiring a Digestive Stoma for Fecal Diversion (RESTODIG)

Crohn Disease | Anastomotic Leak Rectum | Colorectal Anastomosis | Adenomatous Polyposis Coli, Familial | Endometrial | Ulcerative Colitis (Disorder) | Digestive Cancers | Protectomy
NCT01852851

Active, not recruiting

Employment and Arthritis: Making it Work (MIW)

Rheumatoid Arthritis | Lupus Erythematosus, Systemic | Spondylarthropathy | Psoriatic Arthritis | Ankylosing Spondylitis | Other Connective Tissue Diseases
NCT07344129

Completed

Learning in Pairs in Episiotomy Training

Learning in Pairs | Episiotomy Practice
NCT01556659

Terminated

LV Thrombus After Acute AMI: A Randomized Controlled Trial

Ventricular Thrombosis Mural Following Myocardial Infarction
NCT04193969

Completed

Changes in Radicular Pain and Pain Modulation

Back Pain | Back Pain With Radiation
NCT07231926

Recruiting

Intrathecal Morphine for Recovery and Outcomes After VATS (IMPROVE-VATS)

Postoperative Pain Management in Video-Assisted Thoracoscopic Surgery
NCT00716625

Completed

Special Investigation For Renal Cell Carcinoma (RCC) Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan)

Carcinoma, Renal Cell
NCT00270413

Completed

SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer

Metastatic Breast Cancer
NCT01934452

Completed

Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC Patients (APERCU)

Complete Remission in Renal Cell Carcinoma
NCT00709995

Completed

A Study for Participants With Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma
NCT02705638

Completed

Treatment of IgG4-Related Disease With Revlimid and Rituximab (TIGR2)

IgG4-related Disease | Retroperitoneal Fibrosis | Autoimmune Pancreatitis | IgG4-related Sclerosing Cholangitis | Immunoglobulin G Subclass 4 Related Disease
NCT01661972

Completed

Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer (X-TRAP)

Metastatic Colorectal Cancer
NCT00599313

Completed

Phase II Sunitinib Prog Met AIPC

Metastatic Prostate Cancer

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations